The store will not work correctly when cookies are disabled.
1-Ethyl-4-oxo-N-(pyridin-2-ylmethyl)-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
ID: ALA565170
PubChem CID: 17893056
Max Phase: Preclinical
Molecular Formula: C19H16F3N3O2
Molecular Weight: 375.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCn1cc(C(=O)NCc2ccccn2)c(=O)c2cc(C(F)(F)F)ccc21
Standard InChI: InChI=1S/C19H16F3N3O2/c1-2-25-11-15(18(27)24-10-13-5-3-4-8-23-13)17(26)14-9-12(19(20,21)22)6-7-16(14)25/h3-9,11H,2,10H2,1H3,(H,24,27)
Standard InChI Key: KAFKXSZHWOCIRW-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.4715 1.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4715 0.3001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1859 -0.1124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1859 1.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9004 1.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9004 0.3001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6149 -0.1124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3293 0.3001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3293 1.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6149 1.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6149 2.3626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0438 1.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7583 1.1251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0438 2.3626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6149 -0.9374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3293 -1.3499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4728 1.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1872 1.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9017 1.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6162 1.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6162 0.3001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9017 -0.1124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1872 0.3001 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7570 1.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0425 1.9501 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.1695 2.2521 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.3445 0.8231 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
3 6 2 0
12 14 2 0
1 2 2 0
7 15 1 0
5 4 2 0
15 16 1 0
4 1 1 0
13 17 1 0
5 10 1 0
17 18 1 0
6 7 1 0
18 19 2 0
7 8 1 0
19 20 1 0
8 9 2 0
20 21 2 0
9 10 1 0
21 22 1 0
5 6 1 0
22 23 2 0
23 18 1 0
10 11 2 0
1 24 1 0
24 25 1 0
9 12 1 0
24 26 1 0
2 3 1 0
24 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 375.35 | Molecular Weight (Monoisotopic): 375.1195 | AlogP: 3.37 | #Rotatable Bonds: 4 |
Polar Surface Area: 63.99 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.58 | CX Basic pKa: 4.14 | CX LogP: 2.61 | CX LogD: 2.61 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.76 | Np Likeness Score: -2.00 |
References
1. Niedermeier S, Singethan K, Rohrer SG, Matz M, Kossner M, Diederich S, Maisner A, Schmitz J, Hiltensperger G, Baumann K, Holzgrabe U, Schneider-Schaulies J.. (2009) A small-molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion., 52 (14): [PMID:19499921] [10.1021/jm900411s] |